Abstract
Introduction

In the central nervous system (CNS), the astrocyte subtype of glial cells forms a continuous syncytium of highly fibrous cells with a dense core of processes interposed between neuronal elements, some of these cells also contacting local vasculature
. While providing for the physical and metabolic supports to neurones, the astrocytes also play a critical role as controllers of the extracellular space, regulating local pH and ion homeostasis and the reuptake of released neurotransmitters, functions that are essential for normal neuronal activity. Astrocytes were also seen as passive contributors to synaptic transmission, with very little electrical activity propagating through the glial syncitium, because of the abundant expression of Kϩ preventing cellular depolarization [2] . This electrical silence justified the experimental silence surrounding these cells until the mid 1980s [3, 4] (Ca 2ϩ ) elevations [5] [6] [7] , which can be triggered by neuronal activity or by the exogenous application of a variety of neurotransmitters or neuropeptides (for review, see [8] ).
. However in the last couple of decades, advances in quantitative calcium imaging techniques, combined with the development of confocal microscopy and electrophysiological patch-clamp recordings, have challenged this view of astrocytes as passive bystanders. Many results demonstrate now that astrocytes exhibit a specific form of cellular excitability based on intracellular calcium
D-serine in the brain: regional expression and synaptic turnover
Although it took rather long to become established (see [8, 18] for reviews), the in situ existence of neurotransmitters such as glutamate in the brain tissue made acceptable the possibility that these neurotransmitters might also contribute to the neuronal-glial communication-regulating functional integration in the brain. For D-serine, such a case was much less evident, since the free D-amino acids were initially considered as unnatural in tissues of higher species [19] and were thought to be active only in lower organisms, where they constitute a major element of cell walls of bacteria and control their rate of growth [20, 21] [22] [23] [24] [25] [26] [27] [28] . In contrast, D-serine expression is developmentally regulated in the cerebellum, decreasing to trace levels after the first post-natal weeks [25] [26] [27] . [29, 30] [31, 32] . High concentrations of D-serine also occur in astrocytes surrounding local vasculature [28, 31, 32] [32, [34] [35] [36] . Whether these respective sources contribute to modifying the free D-serine concentration at the synaptic cleft still remains equivocal, at least considering the striking numeric prevalence of astrocytes over neurones and given that a substantial release of D-serine from microglia cells requires pro-inflammatory stimuli [35, 37] . At subcellular levels, D-serine may be differentially compartmentalized depending on cellular types [34, 38] [32, 38] . In contrast, treatment of neuronal preparations with bafilomycin A1, another potent blocker of the vesicular uptake of transmitters, is ineffective in modulating D-serine release [34] . In addition, vesicles isolated from cortical neurones that are filled up with conventional transmitters, do not incorporate D-serine, indicating that the neuronal pool of the amino acid is localized in a cytosolic non-vesicular compartment.
. The discovery of free D-aspartic acid in the brain of rodents and man, the localization of D-aspartate in specific neuronal populations and the characterization of uptake and release properties in primary cultures of astrocytes and cerebellar granule cells were successive indications for a functional role of D-amino acids in the brain of higher organisms
. The refinement of HPLC and in vivo microdialysis techniques, together with the use of stereoselective antibodies in immunohistochemical experiments now indicate that D-serine is predominantly confined to the brain, particularly concentrated in the cerebral cortex, hippocampus, striatum and amygdala in adult mammals
An interesting view is that the regional distribution of D-serine complements that of another amino acid glycine, which is rather concentrated in the adult cerebellum, pons and spinal cord. Glycine, in addition to acting through strychnine-sensitive inhibitory receptors, is also known as an obligatory co-agonist required for the activation of the N-methyl-D-aspartate receptors (NMDA-R)
The issues of whether D-serine is synthesized, released and metabolized in situ in the brain are prerequisites in considering this amino acid as a signalling molecule (Fig. 1) . Compelling evidence indicates that all of these criteria are achieved [15] [16] [17] [46] . Other, different splice forms occur in heart, skeletal muscle, kidney and liver tissues with at least three different sizes [43] . Initially confined to astrocytes [41, 42] , SR both at RNA messenger and protein levels has been recently demonstrated also in neuronal cell bodies and processes in the forebrain and cerebellum [34, 36, 47] . The physiological relevance of this pool of neuronal SR still remains elusive and it was recently proposed that neurones predominantly synthesized Dserine whereas astrocytes preferentially accumulated the amino acid [48] . Another possibility is that neuronal SR could underlie the activation of cortical NMDA-R by D-serine through an autocrine or paracrine pathway [34] . Serine racemase activity is modulated by a variety of cofactors, likely to be present in the vicinity of the enzyme (reviewed in [49] [55] . The interaction between SR and GRIP occurs in vivo since these proteins coimmunoprecipitate from brain extracts, and this association is required to trigger neuronal migration of granule cells within the developing cerebellum [55] . [56] . Another scaffolding protein for glutamate receptors, PICK1, also binds SR through its single PDZ domain [57] . Although the physiological relevance of this interaction has yet to be established, it may help for SR activation by promoting the phosphorylation of the enzyme by protein kinase C, known to interact tightly with PICK1 [58] . Indeed, it was recently reported that levels of D-serine is selectively decreased in the forebrain of PICK1 knockout mice whilst the levels of SR protein remains unchanged [59] . Not only the activation, but also the degradation of SR is dependent on protein-protein interactions. Serine racemase is degraded by the ubiquitin-proteasome system, which mediates selective catabolization of many short-lived proteins [60] . [61] .
Although the PDZ6 domain of GRIP selectively interacts with the C-terminal portion of SR, short constructs restricted to this domain are unable to induce SR activation in COS7 cells and larger constructs involving PDZ4-5-6-7 and GAP2 domains are necessary, indicating that GRIP acts on SR by inducing a large conformational changes
The use of yeast two-hybrid technique recently demonstrated, both in vitro and in vivo, that the degradation of SR by the ubiquitin-proteasome system is prevented by its binding with the Golgin subfamily A member 3 (Golga3), a protein implicated in Golgi structure and membrane traffic. The protein interaction, which involves the coiled-coil domain of Golga3, decreases ubiquitylation and degradation rate and significantly enhances SR half-life, and constitutes an alternative way for regulating D-serine levels in the brain
While the biosynthetic pathways for D-serine are now well characterized, the mechanisms regulating the storage, release and reuptake of the amino acid at synaptic cleft still remain to be clarified. The basic observation is that the activation of AMPA and metabotropic subtypes of glutamate receptors in vitro induces the release of D-serine [31, 38, 55] . However, these effects are less convincing in in vivo experiments [62, 63] . The AMPA-evoked [38, 55] [26] .
D-serine release, both in glioma C6 cells and primary astrocytes, involves the SR-GRIP interaction and requires an increase in intracellular calcium concentration
The alternative pathway is that of D-serine being released from the cytoplasmic compartment through a calcium-independent mechanism, such as the activation of a membrane channel driven by a chemical gradient [67] [31, [75] [76] [77] and its genetic deletion substantially increases D-serine levels in the hindbrain and cerebellum [78, 79] where the enzyme is highly expressed and confined in astrocytes [31, [75] [76] [77] . Interestingly, the activity of DAAO is enhanced by nitric oxide, indicating that the effect of NMDA-R to reduce the availability of D-serine occurs not only through the down-regulation of SR but also through an up-regulation of the degradation pathway [80] .
Although substantial immunoreactivity for DAAO has recently been found in human prefrontal cortex [44] , its enzymatic activity is virtually undetectable in the telecephalon [81] [15] [16] [17] 49] ). Pre-treatment with DAAO potently reduced the spontaneous or agonistevoked NMDA-R-mediated currents in hippocampal neuronal cell cultures [88] as well as the NMDA-R-mediated excitatory postsynaptic currents (EPSCs) electrically evoked at CA3-CA1 synapses of hippocampal slices [89] . In the same way, NMDA-R activation was impaired by DAAO in the hypothalamic supraoptic nucleus (SON), an area enriched in D-serine and where SR is highly expressed by astrocytes, whereas a pre-treatment with glycine oxidase to deplete the levels of glycine had no effect [90] [91] [92] [93] . An important issue is that D-serine-mediated activation of NMDA-R was larger in pyramidal cells than in neighbouring GABAergic interneurones within CA1 hippocampal subfield [94] , probably reflecting assemblies of diverse NMDA-R subunits that differentially respond to the agonist [87] . [95] . It is worth noticing that a similar increase occurs at CA3-CA1 hippocampal synapses in these animals [96] , indicating that DAAO activity significantly contributes to limit D-serine levels in the forebrain, at least in the hippocampus, despite the fact that the expression of the enzyme is very low in this territory [28, [75] [76] [77] [89] . Moreover, a pretreatment of neuronal-glial co-cultures or hippocampal slices with DAAO also abolishes LTP expression [89, 101] [90] . [103] [104] [105] [25] [26] [27] . The ability of D-serine to affect the activation of GluR␦2 receptors [109] [55] . Together, these experimental observations raise the possibility that D-serine-mediated neuronal-glial communication has a crucial role in the establishment of appropriate connections in the developing brain.
These findings indicate that beyond its primary role in activating NMDA-R, D-serine is also a dynamic partner involved in the regulation of excitation-inhibition balance within neuronal networks. Endogenous D-serine also underlies NMDA-R activation outside the CNS, thus participating in the encoding of sensory inputs. Mutant mice with genetic deletion of DAAO display larger NMDA-R-mediated EPSCs at spinal cord dorsal horn neurons compared to wild-type controls
. Also, D-serine and SR are present in Müller cells and astrocytes, the two major glial cell types in the retina [97]. A pre-treatment with DAAO or D-serine deaminase, another D-serine degrading enzyme, reduces NMDA-R evoked currents as well as the NMDAr component of light-evoked synaptic responses in retinal ganglion cells [97, 98], which further extends the view of D-serine as a gliotransmitter necessary required for neuronal encoding of presynaptic inputs. NMDA-R are a class of glutamate receptors involved in inducing lasting changes in synaptic strength between neurones, a form of functional plasticity proposed as to underlie cellular memory within neuronal networks. Forms of both long-term potentiation (LTP) or depression (LTD) of synaptic transmission may be driven by NMDA-R activation depending on the amplitude and kinetics of calcium influx flowing through the receptor, and which alters the
. In the hypothalamic SON, a reversible decrease in astrocytic enshealthing of neurones occurs during lactation that down-regulates the occupancy of glycine-binding sites of NMDA-R by D-serine at synaptic cleft [90]. Consequently, the expression of NMDA-R-mediated synaptic plasticity is shifted toward higher activity values, a shift which is proposed to emphasize the activation of specific bursting firing neurones within SON such as those involved in suckling
Thus, synaptic levels of D-serine appears as a prominent component of the neuronal-glial dialogue necessary for the brain to challenge changes in physiological or hormonal environment. Although D-serine was initially thought to act specifically on NMDA-R, it may also affect the activation of AMPA/kainate receptors that underlies the fast glutamatergic transmission in most parts of the brain. In acutely isolated hippocampal neurones, D-serine, but not L-serine, reduces kainate-induced currents, acting as a weak competitive antagonist of the receptor [102]. In hippocampal slice preparations, the amino acid, as well as the partial agonist D-cycloserine, decreases AMPA-R-mediated synaptic responses, but indirectly through the activation of strychnine-sensitive inhibitory glycinergic receptors
and the fact that the genetic deletion and naturally occurring mutations of GluR␦2 genes cause abnormal function of the parallel fibre-to-Purkinje cell and climbing fibre-to-Purkinje cell synapses [108] are further arguments in considering the binding of D-serine to GluR␦2 receptors as important factors during the synaptogenesis in the developing cerebellum. This mechanism is in addition to the property of D-serine released from Bergmann cells to promote, through the activation of NMDA-R, the migration of granule cells from the external to the internal granular layer in the cerebellum of neonatal mice
D-serine signalling in normal aging and Alzheimer's disease
Even today, the exact nature of cellular and molecular substrates underlying learning and memory still remains an opened issue for the neurobiologist. However, this question has always been with us since the constant increase of the age of the population, driven by progress in the prevention and the treatment of chronic diseases and the improvements in hygiene and nutrition, has been
shown to correlate with a higher incidence of cognitive defects, notably of learning and memory. The current hypothesis views memory formation as determined by the capacity of brain neuronal networks to express synaptic plasticity [100] . [110, 111] and is rescued in aged rats and senescenceaccelerated mice by exogenous D-serine [101, 112] . These findings raise the intriguing possibility that changes in D-serine signalling in the age-related could be contributors to the dysfunctions of memory processing (Fig. 2) . Impaired activation of NMDA-R by D-serine indeed occurs in aged tissues; it does not involve either a lower density of receptor or an altered affinity of D-serine-binding sites [113, 114] but a reduced level of the endogenous co-agonist [32, 101, 103] . To what extent the individual molecular determinants involved in synaptic storage of D-serine is affected by aging, has yet to be definitively established. A weaker expression of SR both at transcriptional and post-transcriptional levels indicates that impaired synthesis significantly contributes to the age-related decrease in D-serine levels [101] . It is possible that the degradation of the amino acid might not be affected since DAAO expression is unchanged [101] , although the elimination of D-serine by the SR-dependent elimination-activated pathway may be affected. The ability of D-serine to prevent the age-related deficit of synaptic plasticity would make this amino acid an attractive tool in reducing memory dysfunctions in the aged. It is worth noticing that defects of spatial memory in aged rats [115, 116] and the disruption of the associative hippocampus-dependent eye-blink conditioning in old rabbits [117] are rescued by the partial agonist D-cycloserine, which also alleviates the age-related deficit of NMDA-R-mediated synaptic plasticity by acting on the glycine-binding site [118] . Unfortunately, the possibility of longterm treatments with large doses of D-cycloserine as well as with D-serine itself to rescue cognitive deficits has been discarded because they cause central side effects or induce DAAO-dependent necrosis of the terminal portions of the proximal renal tubules respectively [119] [120] [121] . Alternately, the fact that SR activity is selectively affected in aged tissues opens new perspectives in the search of relevant strategies for reducing memory impairment associated with aging.
As a corollary to this postulate, a deficit in memory abilities should be linked to a parallel impairment of LTP and/or LTD induction at synapses. Normal aging is indeed a case in point, as demonstrated by numerous behavioural and electrophysiological studies performed mainly on rodents (see [109] for a review). The alteration of LTP expression is unambiguously related to a deficit of NMDA-R activation
One striking feature of aging is that the degree of cognitive impairment can greatly vary amongst individuals, from a mild deficit to a severe dementia in the case of Alzheimer's disease (AD). Among the multiple aspects constituting the pathophysiology of AD, the excitotoxicity-induced cell and synapse loss driven by excessive exposure to glutamate and overstimulation of NMDA-R is now considered as a potent mechanism [122] . Indeed, the uncompetitive low-affinity NMDA-R blocker memantine, which enters the receptor-associated ion channel preferentially when it is excessively opened, not only protects against neurodegeneration but also improves cognitive deficits in AD patients and slows down the progression of the disease [123, 124] . Activation of microglial cells, as part of a chronic inflammatory response, is the prominent component of AD that drives neurototoxicity through the release of excitotoxins including glutamate [125, 126] . The amyloid ␤-peptide (A␤) and the secreted form of ␤-amyloid precursor protein, two soluble factors involved in the pathogenesis of AD, not only promote glutamate release from microglia but, at the same time, stimulate SR expression and D-serine release from these glial cells [35, 37] . The transcriptional induction of SR by A␤, which fits with the increase in messenger RNAs for SR in the brain of AD subjects [35] , is promoted by the binding of inducible proto-oncogenes c-fos and JunB to the activator protein-1 sequence present on the first intron of SR gene [127] . A␤ also promotes SR activity post-transcriptionally through an increase in intracellular levels of calcium which up-regulates the activity of the enzyme [51] . On the other hand, SR-independent pathway may also underlie the A␤-mediated increase in D-serine synthesis since the peptide activates L-phosphoserine phosphatase, an enzyme converting the endogenous isomer L-phosphoserine into L-and D-serine [128] . Rather curiously the issue of whether the levels of free D-serine are enhanced in the brains of AD is still a matter of debate in the literature (see [49] (Fig. 2) . Accordingly, it is worth noticing that conditioned media from A␤-treated microglia, containing elevated levels of D-serine, evoke a dramatic overload of calcium in neurones [35] while enzymatic degradation of the amino acid by DAAO or D-serine deaminase protects against cell death elicited by NMDA in vitro [129, 130] [132] . [135] . Several studies tried to determine the molecular and cellular mechanisms that might link impaired NMDA-R activation in schizophrenia with the signalling of D-serine (Fig. 2) [137, 138] . However, no consensus has been reached yet regarding the changes in SR protein levels in the cerebral cortex of schizophrenic subjects -both increased and decreased expression have been reported (see [44] [31, [75] [76] [77] . However, recent evidence showed the unequivocal expression of DAAO in the human cerebral cortex [44, 136] . In addition, there are emerging views considering the cerebellum as an integral part of the circuitry affected in neuropsychiatric disorders, in general and in schizophrenia, in particular [142] . The cerebellar expression of DAAO is up-regulated in brains of schizophrenic subjects [44, 81] while protein levels of the enzyme are elevated in the hippocampus [136] . Interestingly, the hippocampal increase in DAAO expression correlates with duration of illness, not with age [136] , and this is a strong support for the view that changes in DAAO activity are an aetiological mechanism giving rise to NMDA-R dysfunction in schizophrenia [133] .
Conclusions
During the last decades, our knowledge regarding the neuronalglial communication as a potent cellular substrate involved in brain information processing has markedly increased [8, [10] [11] [12] 
